¹⁸F-FDG PET-CT for the prediction of mortality in patients with dermatomyositis and without malignant tumors: a pilot study.

ABSTRACT:

Background

¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography (¹⁸F-FDG PET-CT) is typically used to screen malignancy in patients with dermatomyositis (DM). The aim of this study was to investigate the value of using PET-CT in assessing the prognosis of patients with DM and without malignant tumors.

Methods

A total of 62 patients with DM who underwent ¹⁸F-FDG PET-CT were enrolled in the retrospective cohort study. Clinical data and laboratory indicators were obtained. The muscle max standardized uptake value (SUV_max), splenic SUV_max, target-to-background ratio (TBR) of the aorta, pulmonary highest value (hv)/SUV_max, epicardial fat volume (EFV), and coronary artery calcium (CAC) were measur

SUBMITTER: Xu Y 

PROVIDER: S-EPMC10239996 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature